We show that the effect of combined treatment on MMP-1 and MMP-13 is observed at the protein level, where the addition of both ligands leads to decreased collagen destruction by IL-1β-activated SW-1353 chondrosarcoma cells over single-ligand treatment. The gene discussed is MMP1; the disease is chondrosarcoma.